Samuel Kintz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Samuel Kintz
Samuel Kintz is recorded as CEO at Enliven Therapeutics, Inc. (ELVN). Enliven Therapeutics, Inc. reported in an 8-K filed March 1, 2023 that Samuel Kintz was appointed President and Chief Executive Officer, effective February 23, 2023.
“Following the Closing, your employment will continue as President and Chief Executive Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Enliven Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Richard Fair CEO, Board Member
- Rick Fair CEO, Board Member
- Sam Kintz, M.B.A. CEO, Board Member
- Richard Heyman, Ph.D. Chairman, Board Member
- Ben Hohl CFO
- Benjamin Hohl CFO
- Anish Patel COO
- Andrew Phillips, Ph.D. Board Member
- Continuing Directors Board Member
- Jake Bauer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.